OKYO - OKYO Pharma reports FY results August, 16 2022 02:24 AM OKYO Pharma Limited OKYO Pharma press release ( NASDAQ: OKYO ): FY total comprehensive loss of £3,976k (2021: £2,994k) Cash balance at 31 March 2022 £2,056k (31 March 2021: £4,992k). For further details see: OKYO Pharma reports FY results